SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 85 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $45,000 | +2.3% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $44,000 | +46.7% | 2,000 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $30,000 | 0.0% | 2,000 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $30,000 | +36.4% | 2,000 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $22,000 | +22.2% | 2,000 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $18,000 | +20.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $15,000 | -21.1% | 2,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $19,000 | +72.7% | 2,000 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $11,000 | +22.2% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $9,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,168,691 | $30,297,000 | 13.16% |
Boxer Capital, LLC | 234,220 | $3,272,000 | 0.78% |
SPHERA FUNDS MANAGEMENT LTD. | 296,310 | $4,139,000 | 0.70% |
Ghost Tree Capital, LLC | 200,000 | $2,794,000 | 0.58% |
Eventide Asset Management | 225,000 | $3,143,000 | 0.20% |
Vident Investment Advisory, LLC | 103,558 | $1,447,000 | 0.12% |
J. Goldman & Co LP | 147,181 | $2,056,000 | 0.11% |
TIVERTON ASSET MANAGEMENT LLC | 137,732 | $1,924,000 | 0.10% |
Crestline Management, LP | 55,368 | $773,000 | 0.10% |
Tekla Capital Management LLC | 200,000 | $2,794,000 | 0.10% |